• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同蝎毒抗原诱导的小鼠血清的中和能力

Neutralizing capacity of murine sera induced by different antigens of scorpion venom.

作者信息

Calderon-Aranda E S, Hozbor D, Possani L D

机构信息

Departamento de Bioquímica, Universidad Nacional Autónoma de México, Cuernavaca.

出版信息

Toxicon. 1993 Mar;31(3):327-37. doi: 10.1016/0041-0101(93)90150-h.

DOI:10.1016/0041-0101(93)90150-h
PMID:8470136
Abstract

Approximately 700 people die in Mexico each year from scorpion stings. The only useful therapy available is antiserum obtained from horses immunized with macerates of venomous gland from scorpions of the genus Centruroides. We report the results of experiments conducted with mice and rats in order to evaluate the relevant components of the venom from Centruroides noxius in the induction of a protective response against scorpion envenomation, either in vivo or in vitro. Gland macerates of whole telsons (stinger), soluble venom extracted by electrical stimulation, toxic fractions from gel filtration on Sephadex G-50 and highly purified toxin 2 from this scorpion venom were all used to produce hyperimmune mice and rats, which were challenged in vivo with the equivalent of the lethal dose 50% (LD50) of soluble venom, or their sera were prepared for in vitro neutralization experiments using non-immunized animals. The maximum neutralizing capacity (100%) was obtained when soluble venom was used as antigen, while purified toxin 2 produces 80% survival in vivo. The neutralizing capacity of murine antisera evaluated in vitro was: sera antifraction II > antitoxin 2 > antitotal venom > anti-gland macerates of whole telsons. Two additional aspects were further investigated in the present work. One is the demonstration by immunoblotting that proteins corresponding to the electrophoretic mobility of toxins known to block sodium channels are highly immunodominant in this venom. Second, there is a strong cross-reactivity of antisera produced with Centruroides noxius when assayed against venoms from other dangerous species of Centruroides scorpions from Mexico, but not against the Israeli scorpion Leiurus quinquestriatus. Finally, the immunodominance of toxic fractions in the immune response was observed either with immunization using Freund's adjuvant or by means of adsorption to nitrocellulose membranes. This latter vehicle was shown to be an excellent detoxifying agent, without changing the immunogenicity of the toxins, as might occur with chemical treatment of these neurotoxic peptides.

摘要

在墨西哥,每年约有700人死于蝎子蜇伤。唯一有效的治疗方法是使用抗血清,该抗血清是从用墨西哥毒蝎属蝎子的毒腺浸液免疫过的马身上获取的。我们报告了用小鼠和大鼠进行实验的结果,以评估墨西哥毒蝎毒液的相关成分在体内或体外诱导针对蝎子蜇伤的保护性反应中的作用。整个毒刺的腺体浸液、通过电刺激提取的可溶性毒液、在葡聚糖凝胶G - 50上进行凝胶过滤得到的有毒组分以及从这种蝎子毒液中高度纯化的毒素2,均用于制备超免疫小鼠和大鼠,然后用相当于可溶性毒液半数致死剂量(LD50)的剂量在体内对它们进行攻击,或者制备它们的血清用于使用未免疫动物进行的体外中和实验。当使用可溶性毒液作为抗原时,可获得最大中和能力(100%),而纯化的毒素2在体内可使80%的动物存活。在体外评估的鼠抗血清的中和能力为:抗组分II血清>抗毒素2>抗总毒液>抗整个毒刺的腺体浸液。在本研究中还进一步调查了另外两个方面。一是通过免疫印迹法证明,在这种毒液中,与已知能阻断钠通道的毒素电泳迁移率相对应的蛋白质具有高度免疫显性。二是当用墨西哥毒蝎产生的抗血清检测来自墨西哥其他危险的毒蝎属蝎子的毒液时,存在强烈的交叉反应,但对以色列蝎子黄肥尾蝎则无交叉反应。最后,无论是使用弗氏佐剂免疫还是通过吸附到硝酸纤维素膜上,都观察到了有毒组分在免疫反应中的免疫显性。事实证明,后一种载体是一种极好的解毒剂,不会像对这些神经毒性肽进行化学处理那样改变毒素的免疫原性。

相似文献

1
Neutralizing capacity of murine sera induced by different antigens of scorpion venom.不同蝎毒抗原诱导的小鼠血清的中和能力
Toxicon. 1993 Mar;31(3):327-37. doi: 10.1016/0041-0101(93)90150-h.
2
Design and expression of recombinant toxins from Mexican scorpions of the genus Centruroides for production of antivenoms.用于生产抗蛇毒血清的来自墨西哥Centruroides属蝎子的重组毒素的设计与表达。
Toxicon. 2017 Mar 15;128:5-14. doi: 10.1016/j.toxicon.2017.01.015. Epub 2017 Jan 23.
3
Fab fragments of the monoclonal antibody BCF2 are capable of neutralizing the whole soluble venom from the scorpion Centruroides noxius Hoffmann.单克隆抗体BCF2的Fab片段能够中和来自墨西哥毒蝎霍夫曼氏毒蝎的全溶性毒液。
Toxicon. 1996 Aug;34(8):843-7. doi: 10.1016/0041-0101(96)00043-8.
4
A novel human recombinant antibody fragment capable of neutralizing Mexican scorpion toxins.一种能够中和墨西哥蝎子毒素的新型人源重组抗体片段。
Toxicon. 2013 Dec 15;76:370-6. doi: 10.1016/j.toxicon.2013.09.016. Epub 2013 Sep 22.
5
Preparation of a polyvalent antivenom against various Mexican scorpion Centruroides species.针对多种墨西哥蝎属(Centruroides)蝎子的多价抗蛇毒血清的制备。
Toxicon. 1988;26(11):1102-6. doi: 10.1016/0041-0101(88)90211-5.
6
Analysis of the immune response induced by a scorpion venom sub-fraction, a pure peptide and a recombinant peptide, against toxin Cn2 of Centruroides noxius Hoffmann.对蝎毒亚组分、一种纯肽和一种重组肽诱导的针对墨西哥毒蝎(Centruroides noxius Hoffmann)毒素Cn2的免疫反应的分析。
Toxicon. 2003 Mar;41(4):417-27. doi: 10.1016/s0041-0101(02)00337-9.
7
In vivo protection against Tityus serrulatus scorpion toxins by immunization of mice with a non-toxic protein.通过用无毒蛋白免疫小鼠对锯齿脂鲤属蝎子毒素进行体内保护。
Toxicon. 1998 Feb;36(2):333-9. doi: 10.1016/s0041-0101(97)00103-7.
8
New and safe formulation for scorpion immunotherapy: Comparative study between saponin and FCA adjuvants associated to attenuated venom.新型安全的蝎类免疫治疗制剂:皂苷与 FCA 佐剂联合减毒毒液的比较研究。
Vaccine. 2018 Mar 20;36(13):1720-1727. doi: 10.1016/j.vaccine.2018.02.071. Epub 2018 Feb 23.
9
Amino acid sequence and immunological characterization with monoclonal antibodies of two toxins from the venom of the scorpion Centruroides noxius Hoffmann.霍夫曼氏毒蝎(Centruroides noxius Hoffmann)毒液中两种毒素的氨基酸序列及单克隆抗体免疫特性分析
Eur J Biochem. 1992 Feb 15;204(1):281-92. doi: 10.1111/j.1432-1033.1992.tb16635.x.
10
General biochemical and immunological characterization of the venom from the scorpion Tityus trivittatus of Argentina.阿根廷三刺多毛蝎毒液的一般生化和免疫特性。
Toxicon. 2010 Feb-Mar;55(2-3):307-19. doi: 10.1016/j.toxicon.2009.08.014. Epub 2009 Aug 23.

引用本文的文献

1
Toxic peptides and genes encoding toxin gamma of the Brazilian scorpions Tityus bahiensis and Tityus stigmurus.巴西蝎子巴伊亚肥尾蝎和标记肥尾蝎的毒性肽及编码毒素γ的基因。
Biochem J. 1996 Feb 1;313 ( Pt 3)(Pt 3):753-60. doi: 10.1042/bj3130753.